Latest period
−$29.34M
YoY change
-40.4%
5Y CAGR
—
Peak year (2018)
−$8.57M
Latest annual
−$33.33M
Free Cash Flow history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: −$33.33M
Free Cash Flow growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -40.4%
Free Cash Flow history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | −$33.33M | -40.4% | +$22.64M | ||
| 2024 | −$55.96M | +68.2% | −$22.68M | ||
| 2023 | −$33.28M | -20.2% | +$8.41M | ||
| 2022 | −$41.69M | +15.9% | −$5.72M | ||
| 2021 | −$35.97M | +30.4% | −$8.38M | ||
| 2020 | −$27.59M | +118.6% | −$14.97M | ||
| 2019 | −$12.62M | +47.3% | −$4.05M | ||
| 2018 | −$8.57M | — | — |
- 2025−$33.33M-40.4%
- 2024−$55.96M+68.2%
- 2023−$33.28M-20.2%
- 2022−$41.69M+15.9%
- 2021−$35.97M+30.4%
- 2020−$27.59M+118.6%
- 2019−$12.62M+47.3%
- 2018−$8.57M—
Free Cash Flow values are taken from Spruce Biosciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Spruce Biosciences (SPRB)
Free Cash Flow for Spruce Biosciences (SPRB): headline value −$29.34M · YoY -40.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Spruce Biosciences (SPRB) came in at −$33.33M – plunged 40.4% year-over-year.
−$8.57M stands as the all-time-high annual free cash flow, posted in 2018, against a low of −$55.96M during 2024.
Spruce Biosciences Free Cash Flow by Year
Spruce Biosciences Free Cash Flow 2025: −$33.33M
In 2025, Spruce Biosciences reported free cash flow of −$33.33M, plunged 40.4% below 2024.
Spruce Biosciences Free Cash Flow 2024: −$55.96M
Spruce Biosciences free cash flow in 2024 was −$55.96M, surged 68.2% from 2023. This figure represents the lowest annual value in the available history.
Spruce Biosciences Free Cash Flow 2023: −$33.28M
2023's free cash flow for Spruce Biosciences came in at −$33.28M, declined 20.2% below 2022.
Spruce Biosciences Free Cash Flow 2022: −$41.69M
Spruce Biosciences posted free cash flow of −$41.69M in 2022, grew 15.9% from 2021.
Spruce Biosciences Free Cash Flow 2021: −$35.97M
Spruce Biosciences free cash flow in 2021 was −$35.97M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Free Cash Flow
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $11.77B | |
| $8.97B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $11.77B
- $8.97B
- $8.10B
- $4.52B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation